BioLife Solutions, Inc.
BLFS
$25.65
-$0.26-1.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3,435.27% | -103.60% | 831.59% | -- | -- |
| Total Depreciation and Amortization | -0.14% | 194.41% | -163.27% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 377.47% | 144.62% | -288.56% | -- | -- |
| Change in Net Operating Assets | 102.26% | -538.97% | 170.02% | -- | -- |
| Cash from Operations | 326.64% | 4.98% | -65.74% | -25.65% | 244.34% |
| Capital Expenditure | -348.24% | 47.01% | 48.19% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -40.66% | -135.94% | 56,069.17% | -- | -- |
| Cash from Investing | -45.47% | -136.91% | 4,480.55% | 87.49% | -5,979.19% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 27.03% | -26.23% | -- | -- |
| Issuance of Common Stock | -- | -- | 41.30% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 19.51% | 32.14% | -144.56% | -- | -- |
| Cash from Financing | 3.81% | 26.77% | -292.51% | -47.87% | 26.05% |
| Foreign Exchange rate Adjustments | -- | -- | -19.44% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -23.21% | -139.93% | 3,266.02% | 127.55% | -34.43% |